Literature DB >> 18773284

Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis.

Maria Wikén1, Johan Grunewald, Anders Eklund, Jan Wahlström.   

Abstract

INTRODUCTION: Sarcoidosis is an inflammatory disease of unknown etiology. However, an infectious cause has been proposed suggesting a role for pattern-recognition receptors, such as Toll-like receptors (TLRs) and nucleotide-binding domain, leucin-rich repeat containing family proteins (NLRs), in the pathogenesis.
OBJECTIVE: Our aim was to investigate whether differences in TLR2 and TLR4 expression, and the response to TLR2, TLR4, and NOD2 stimulation, are associated with sarcoidosis.
MATERIALS AND METHODS: Blood mononuclear cells from sarcoidosis patients (n = 24) and healthy subjects (n = 19) were incubated with the TLR2 ligands PGN and Pam3CSK4, the TLR4 ligand LPS, the NOD2 ligand MDP, or medium alone. After 16 h, monocyte TLR2 and TLR4 expression and cytokine secretion, including TNFalpha, IL-1 beta, IL-6, IL-8, IL-10, and IL-12p70, were measured using flow cytometry and cytometric bead array.
RESULTS: TLR2 and TLR4 expression at baseline was significantly higher in patients. Combined TLR2 and NOD2 stimulation induced a four-fold higher secretion of TNFalpha and a 13-fold higher secretion of IL-1 beta in patients. Additionally, there was a synergistic effect of TLR2 with NOD2 stimulation on induction of IL-1 beta in patients, whereas IL-10 was synergistically induced in healthy subjects.
CONCLUSION: Increased TLR expression and enhanced secretion of pro-inflammatory cytokines after combined TLR2 and NOD2 stimulation may be related to the pathogenesis of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773284     DOI: 10.1007/s10875-008-9225-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  42 in total

Review 1.  TIR, CARD and PYRIN: three domains for an antimicrobial triad.

Authors:  C Werts; S E Girardin; D J Philpott
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

2.  The bilateral hilar lymphoma syndrome; a study of the relation to tuberculosis and sarcoidosis in 212 cases.

Authors:  S LOFGREN; H LUNDBACK
Journal:  Acta Med Scand       Date:  1952-03-19

3.  Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes.

Authors:  Tsuyoshi Tanabe; Ikuo Ishige; Yoshimi Suzuki; Yukie Aita; Asuka Furukawa; Yuki Ishige; Keisuke Uchida; Takashige Suzuki; Tamiko Takemura; Soichiro Ikushima; Masaru Oritsu; Tetsuji Yokoyama; Yukari Fujimoto; Koichi Fukase; Naohiro Inohara; Gabriel Nunez; Yoshinobu Eishi
Journal:  Biochim Biophys Acta       Date:  2006-07-25

4.  Different Toll-like receptor agonists induce distinct macrophage responses.

Authors:  B W Jones; T K Means; K A Heldwein; M A Keen; P J Hill; J T Belisle; M J Fenton
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

5.  Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis.

Authors:  F Idali; M Wikén; J Wahlström; H Mellstedt; A Eklund; H Rabbani; J Grunewald
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

6.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

Authors:  Nobuo Kanazawa; Ikuo Okafuji; Naotomo Kambe; Ryuta Nishikomori; Mami Nakata-Hizume; Sonoko Nagai; Akihiko Fuji; Takenosuke Yuasa; Akira Manki; Yoshihiko Sakurai; Mitsuru Nakajima; Hiroko Kobayashi; Ikuma Fujiwara; Hiroyuki Tsutsumi; Atsushi Utani; Chikako Nishigori; Toshio Heike; Tatsutoshi Nakahata; Yoshiki Miyachi
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

7.  NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Warren Strober
Journal:  Nat Immunol       Date:  2004-06-27       Impact factor: 25.606

8.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

9.  Cytokine-induced generation of multinucleated giant cells in vitro requires interferon-gamma and expression of LFA-1.

Authors:  J Möst; H P Neumayer; M P Dierich
Journal:  Eur J Immunol       Date:  1990-08       Impact factor: 5.532

10.  NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis.

Authors:  Gerben Ferwerda; Stephen E Girardin; Bart-Jan Kullberg; Lionel Le Bourhis; Dirk J de Jong; Dennis M L Langenberg; Reinout van Crevel; Gosse J Adema; Tom H M Ottenhoff; Jos W M Van der Meer; Mihai G Netea
Journal:  PLoS Pathog       Date:  2005-11-25       Impact factor: 6.823

View more
  27 in total

1.  Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice.

Authors:  Ru Liu-Bryan; Robert Terkeltaub
Journal:  Arthritis Rheum       Date:  2010-07

Review 2.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

Review 3.  Toll like receptors in diseases of the lung.

Authors:  Melissa A Kovach; Theodore J Standiford
Journal:  Int Immunopharmacol       Date:  2011-05-30       Impact factor: 4.932

4.  The rheumatic disease-associated FAM167A-BLK locus encodes DIORA-1, a novel disordered protein expressed highly in bronchial epithelium and alveolar macrophages.

Authors:  L Mentlein; G E Thorlacius; L Meneghel; L A Aqrawi; J I Ramírez Sepúlveda; J Grunewald; A Espinosa; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2018-05-16       Impact factor: 4.330

5.  The expression and function of Nod-like receptors in neutrophils.

Authors:  Anna-Karin Ekman; Lars Olaf Cardell
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

6.  Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study.

Authors:  Giorgos A Margaritopoulos; Katerina M Antoniou; Kostas Karagiannis; Katerina D Samara; Ismini Lasithiotaki; Evi Vassalou; Rena Lymbouridou; Helen Koutala; Nikos M Siafakas
Journal:  Fibrogenesis Tissue Repair       Date:  2010-10-11

7.  No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.

Authors:  Maria Wikén; Farah Idali; Muntasir Abo Al Hayja; Johan Grunewald; Anders Eklund; Jan Wahlström
Journal:  Respir Res       Date:  2010-09-02

8.  Toll-like receptors: role in dermatological disease.

Authors:  Aswin Hari; Tracy L Flach; Yan Shi; P Régine Mydlarski
Journal:  Mediators Inflamm       Date:  2010-08-22       Impact factor: 4.711

Review 9.  Dendritic cells in the pathogenesis of sarcoidosis.

Authors:  Lisa C Zaba; Gideon P Smith; Miguel Sanchez; Stephen D Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

10.  Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis.

Authors:  H L Rosenzweig; M M Jann; T T Glant; T M Martin; S R Planck; W van Eden; P J S van Kooten; R A Flavell; K S Kobayashi; J T Rosenbaum; M P Davey
Journal:  J Leukoc Biol       Date:  2009-01-07       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.